http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109776609-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6506 |
| filingDate | 2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109776609-B |
| titleOfInvention | Novel disodium levoornidazole phosphate hydrate, preparation and application thereof |
| abstract | The invention belongs to the technical field of chemical drugs, and particularly relates to a novel disodium levoornidazole phosphate hydrate, a preparation and application thereof. The novel disodium levoornidazole phosphate hydrate is heptahydrate, the content of the disodium levoornidazole phosphate hydrate in the pharmaceutical composition is 50-2000 mg, and each preparation unit contains 100-1000 mg of the disodium levoornidazole phosphate hydrate. The disodium levoornidazole phosphate hydrate has a stable spatial structure, has better stability compared with other hydrate crystal forms of the compound, can ensure constant quality for a long time, and effectively prolongs the quality guarantee period of the product. |
| priorityDate | 2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.